SCOPA 2022: A review of topical medication classes in eyecare

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Topical Pharmacology Rounds."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation, "Topical pharmacology rounds," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

This is a talk I've given ... throughout the country, and it seems to be a pretty well-received review of basically all topical medication classes that we use in optometry—or eyecare.— in general.

I kind of cover each drug that we have out there, kind of hit on some newer drugs that are just coming to the market, some things in the pipeline a little bit.

And the goal is to give a little bit of background on how the drugs work, and how one drug may be similar or different from another, but my real goal during the talk is always to say, "Okay, here are some clinical nuances between drug X and drug Y," and help attendees better use those medications in their practice to take care of their patients.

We cover antibiotics, anti-inflammatories, nonsteroidal anti-inflammatories, allergy medicines, glaucoma drops, antivirals, and basically every category you can think of.

Recent Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Khanh Hoang at EyeCon 2024 receiving the Visionary in Eye Care Award
Dr Adam Wenick at EyeCon 2024
David Chin Yee, MD, at EyeCon 2024
Dr. Adam Ramsey discusses innovation for your eye care practice at EyeCon 2024
Dr. Leonard Messner at EyeCon 2024
Dr. Adam Wenick at EyeCon 2024
EyeCon 2024: Insights on transforming ocular surface disease management
© 2024 MJH Life Sciences

All rights reserved.